1. Home
  2. NRXP vs SYPR Comparison

NRXP vs SYPR Comparison

Compare NRXP & SYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • SYPR
  • Stock Information
  • Founded
  • NRXP 2015
  • SYPR 1997
  • Country
  • NRXP United States
  • SYPR United States
  • Employees
  • NRXP N/A
  • SYPR N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • SYPR Industrial Machinery/Components
  • Sector
  • NRXP Health Care
  • SYPR Industrials
  • Exchange
  • NRXP Nasdaq
  • SYPR Nasdaq
  • Market Cap
  • NRXP 32.6M
  • SYPR 36.8M
  • IPO Year
  • NRXP N/A
  • SYPR 1994
  • Fundamental
  • Price
  • NRXP $2.09
  • SYPR $1.70
  • Analyst Decision
  • NRXP Strong Buy
  • SYPR
  • Analyst Count
  • NRXP 4
  • SYPR 0
  • Target Price
  • NRXP $28.25
  • SYPR N/A
  • AVG Volume (30 Days)
  • NRXP 124.9K
  • SYPR 20.1K
  • Earning Date
  • NRXP 05-13-2025
  • SYPR 05-14-2025
  • Dividend Yield
  • NRXP N/A
  • SYPR N/A
  • EPS Growth
  • NRXP N/A
  • SYPR N/A
  • EPS
  • NRXP N/A
  • SYPR N/A
  • Revenue
  • NRXP N/A
  • SYPR $140,180,000.00
  • Revenue This Year
  • NRXP N/A
  • SYPR N/A
  • Revenue Next Year
  • NRXP N/A
  • SYPR N/A
  • P/E Ratio
  • NRXP N/A
  • SYPR N/A
  • Revenue Growth
  • NRXP N/A
  • SYPR 2.90
  • 52 Week Low
  • NRXP $1.10
  • SYPR $1.27
  • 52 Week High
  • NRXP $6.01
  • SYPR $3.72
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 53.92
  • SYPR 52.24
  • Support Level
  • NRXP $1.85
  • SYPR $1.56
  • Resistance Level
  • NRXP $2.10
  • SYPR $1.63
  • Average True Range (ATR)
  • NRXP 0.16
  • SYPR 0.10
  • MACD
  • NRXP 0.04
  • SYPR 0.01
  • Stochastic Oscillator
  • NRXP 90.18
  • SYPR 70.37

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About SYPR Sypris Solutions Inc.

Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sales of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.

Share on Social Networks: